Cargando…
Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines
BACKGROUND: Epithelial to mesenchymal transition is a process in which a cell experiences a loss of epithelial cell characteristics and acquires a more mesenchymal cell phenotype. In cancer, epithelial to mesenchymal transition has been proposed to play an important role during specific stages of tu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880289/ https://www.ncbi.nlm.nih.gov/pubmed/27224422 http://dx.doi.org/10.1371/journal.pone.0156310 |
_version_ | 1782433779125583872 |
---|---|
author | Sandquist, Elizabeth J. Somji, Seema Dunlevy, Jane R. Garrett, Scott H. Zhou, Xu Dong Slusser-Nore, Andrea Sens, Donald A. |
author_facet | Sandquist, Elizabeth J. Somji, Seema Dunlevy, Jane R. Garrett, Scott H. Zhou, Xu Dong Slusser-Nore, Andrea Sens, Donald A. |
author_sort | Sandquist, Elizabeth J. |
collection | PubMed |
description | BACKGROUND: Epithelial to mesenchymal transition is a process in which a cell experiences a loss of epithelial cell characteristics and acquires a more mesenchymal cell phenotype. In cancer, epithelial to mesenchymal transition has been proposed to play an important role during specific stages of tumor progression. The role epithelial to mesenchymal transition and mesenchymal to epithelial transition might play in toxicant-induced urothelial cancer is unknown. METHODS: Real-time PCR, Western blotting, immuno-histochemistry and immuno-fluorescence were used to determine the expression of E- and N-cadherin in the UROtsa parent, the As(+3)- and Cd(+2)-transformed cell lines, the spheroids isolated from these cell lines as well as the tumor heterotransplants that were produced by the injection of the transformed cells into immune compromised mice. RESULTS: This study showed that N-cadherin expression was increased in 6 As(+3)- and 7 Cd(+2)- transformed cell lines generated from human urothelial cells (UROtsa). The expression varied within each cell line, with 10% to 95% of the cells expressing N-cadherin. Tumors produced from these cell lines showed no expression of the N-cadherin protein. Spheroids which are made up of putative cancer initiating cells produced from these cell lines showed only background expression of N-cadherin mRNA, increased expression of aldehyde dehydrogenase 1 mRNA and produced tumors which did not express N-cadherin. There was no change in the expression of E-cadherin in the tumors, and the tumors formed by all the As(+3) and Cd(+2)-transformed cell lines and cancer initiating cells stained intensely and uniformly for E-cadherin. CONCLUSIONS: The finding that the cells expressing N-cadherin gave rise to tumors with no expression of N-cadherin is in agreement with the classical view of epithelial to mesenchymal transition. Epithelial to mesenchymal transition and N-cadherin are associated with dissemination and not with the ability to establish new tumor growth. Mesenchymal to epithelial transition and E-cadherin are viewed as necessary for a cell to establish a new metastatic site. The lack of N-cadherin expression in tumor transplants is consistent with E-cadherin expressing cells “seeding” a site for tumor growth. The study shows that a minority population of cultured cells can be the initiators of tumor growth. |
format | Online Article Text |
id | pubmed-4880289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48802892016-06-09 Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines Sandquist, Elizabeth J. Somji, Seema Dunlevy, Jane R. Garrett, Scott H. Zhou, Xu Dong Slusser-Nore, Andrea Sens, Donald A. PLoS One Research Article BACKGROUND: Epithelial to mesenchymal transition is a process in which a cell experiences a loss of epithelial cell characteristics and acquires a more mesenchymal cell phenotype. In cancer, epithelial to mesenchymal transition has been proposed to play an important role during specific stages of tumor progression. The role epithelial to mesenchymal transition and mesenchymal to epithelial transition might play in toxicant-induced urothelial cancer is unknown. METHODS: Real-time PCR, Western blotting, immuno-histochemistry and immuno-fluorescence were used to determine the expression of E- and N-cadherin in the UROtsa parent, the As(+3)- and Cd(+2)-transformed cell lines, the spheroids isolated from these cell lines as well as the tumor heterotransplants that were produced by the injection of the transformed cells into immune compromised mice. RESULTS: This study showed that N-cadherin expression was increased in 6 As(+3)- and 7 Cd(+2)- transformed cell lines generated from human urothelial cells (UROtsa). The expression varied within each cell line, with 10% to 95% of the cells expressing N-cadherin. Tumors produced from these cell lines showed no expression of the N-cadherin protein. Spheroids which are made up of putative cancer initiating cells produced from these cell lines showed only background expression of N-cadherin mRNA, increased expression of aldehyde dehydrogenase 1 mRNA and produced tumors which did not express N-cadherin. There was no change in the expression of E-cadherin in the tumors, and the tumors formed by all the As(+3) and Cd(+2)-transformed cell lines and cancer initiating cells stained intensely and uniformly for E-cadherin. CONCLUSIONS: The finding that the cells expressing N-cadherin gave rise to tumors with no expression of N-cadherin is in agreement with the classical view of epithelial to mesenchymal transition. Epithelial to mesenchymal transition and N-cadherin are associated with dissemination and not with the ability to establish new tumor growth. Mesenchymal to epithelial transition and E-cadherin are viewed as necessary for a cell to establish a new metastatic site. The lack of N-cadherin expression in tumor transplants is consistent with E-cadherin expressing cells “seeding” a site for tumor growth. The study shows that a minority population of cultured cells can be the initiators of tumor growth. Public Library of Science 2016-05-25 /pmc/articles/PMC4880289/ /pubmed/27224422 http://dx.doi.org/10.1371/journal.pone.0156310 Text en © 2016 Sandquist et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Sandquist, Elizabeth J. Somji, Seema Dunlevy, Jane R. Garrett, Scott H. Zhou, Xu Dong Slusser-Nore, Andrea Sens, Donald A. Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title | Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title_full | Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title_fullStr | Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title_full_unstemmed | Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title_short | Loss of N-Cadherin Expression in Tumor Transplants Produced From As(+3)- and Cd(+2)-Transformed Human Urothelial (UROtsa) Cell Lines |
title_sort | loss of n-cadherin expression in tumor transplants produced from as(+3)- and cd(+2)-transformed human urothelial (urotsa) cell lines |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880289/ https://www.ncbi.nlm.nih.gov/pubmed/27224422 http://dx.doi.org/10.1371/journal.pone.0156310 |
work_keys_str_mv | AT sandquistelizabethj lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT somjiseema lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT dunlevyjaner lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT garrettscotth lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT zhouxudong lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT slussernoreandrea lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines AT sensdonalda lossofncadherinexpressionintumortransplantsproducedfromas3andcd2transformedhumanurothelialurotsacelllines |